Dialyzer Membrane Materials | PSf, PES, CTA, PMMA, PEPA, EVAL, PAN

🧬 Dialyzer Membrane Materials PSf · PES · CTA · PMMA · PEPA · EVAL · PAN

Comprehensive guide to synthetic membrane types �?biocompatibility, adsorption properties, and clinical applications

The materials most commonly used to make hollow fiber membranes include PSf, PES, cellulose triacetate (CTA), polymethylmethacrylate (PMMA), PEPA, ethylene vinyl alcohol copolymers (EVAL), and polyacrylonitrile (PAN). The use of poorly biocompatible, unmodified cellulose dialyzer membranes is discouraged.

📊 Market distribution: Most dialyzer membranes are made from synthetic polymers �?93% derived from the parent polyarylsulfone family (71% PSf, 22% PES). Super high-flux dialyzers are primarily PSf and PES.

🌀 PSf Membranes (Polysulfone)

Most widely used membrane material (71% of market). Blended with polyvinylpyrrolidone (PVP) for hydrophilicity.

Removes broad range of uremic toxins
Effectively retains endotoxins
Intrinsic biocompatibility and low cytotoxicity
Higher sieving capability + increased hydraulic permeability �?efficient convection

                    💡 Significant differences among PSf membranes exist due to variations in co-polymer ratios and fiber spinning processes.
                

�?PES Membranes (Polyethersulfone)

22% of market �?advanced fiber spinning creates larger, uniform pores with sharp cut-off.

Outstanding middle molecule removal with minimal albumin loss
Steeper sieving curve for low molecular weight proteins
Highest standards of biocompatibility and endotoxin retention
Hydrophobic base polymers + hydrophilic components optimize solute passage

                    🔬 Historical context: Previously, much higher albumin loss was required to achieve comparable HD treatment efficacy with inferior permselectivity.
                

📜 CTA Membranes (Cellulose Triacetate)

High solute permeability �?removes β2M by diffusion.

Thin fibers with Moiré structure �?uniform dialysate flow distribution
High antithrombogenicity
Improves lipid metabolism
Reduces homocysteine and advanced glycation end products (AGEs)

                    🩸 Hemocompatibility: High albumin adsorption suggests lower activation of coagulation cascade than PSf membranes.
                

🧲 PMMA Membranes (Polymethylmethacrylate)

Highly adsorptive �?homogeneous structure allows entire membrane to contribute to adsorption.

Reduces indoxyl sulphate, p-cresyl sulphate, and CMPF (cardiovascular toxins)
Adsorbs intact PTH �?improves pruritis
Enhances hepatitis B vaccine response
Preserves muscle mass (especially in elderly)

                    💪 Protein-leaking (superflux) PMMA: Reduces CMPF with improvements in anemia, reduces homocysteine, pentosidine, and inflammatory cytokines.
                

🔬 PEPA Membranes (PES + Polyarylate)

Unique three-layer structure: inner skin layer �?porous layer �?outer skin layer.

Outer skin layer blocks endotoxin from dialysate side �?can be used as endotoxin filter
Albumin loss / β2M removal controlled by PVP amount
Versions without PVP �?minimal complement activation (C3a, C5a)

🛡�?Dual function: High permeability and built-in endotoxin retention.

💧 EVAL Membranes (Ethylene Vinyl Alcohol)

Hydrophilic, uncharged, smooth surface �?retains water, minimal protein adsorption.

Minimal platelet activation
Low ROS and proinflammatory cytokine production (IL-6, MCP-1)
May help maintain better peripheral circulation
Long-term use may reduce oxidative stress and inflammation �?reduces vascular disease symptoms

                    ❤️ Vascular benefit: Particularly suitable for patients with peripheral artery disease or high cardiovascular risk.
                

🔄 PAN Membranes (Polyacrylonitrile)

Hydrophilic �?forms hydrogel structure with high diffusive and hydraulic permeability.

Highly specific adsorption within membrane structure (not just surface)
High permeability to fluid and broad spectrum of uremic toxins
Excellent biocompatibility
Removal of MCP-1 achieved through specific adsorption

🔬 Unique property: High specificity for basic, medium-sized proteins.

�?Surface-Modified Membranes

Coatings to improve biocompatibility and reduce complications.

Polyethylene glycol (PEG) coating: Decreases monocyte/granulocyte activation and migration
Vitamin E coating: Reduces hypotension during HD, antioxidant properties
Heparin coating: For heparin-free dialysis in patients with increased bleeding risk

                    ⚕️ Clinical application: Surface modifications particularly useful for intradialytic hypotension and high bleeding risk patients.
                

📊 Membrane Material Comparison: Key Attributes

Membrane	Primary Mechanism	Key Clinical Benefit	Special Feature
PSf	Convection + Diffusion	Broad toxin removal, endotoxin retention	Most common (71% market), blended with PVP
PES	Convection + Diffusion	Sharp cut-off, minimal albumin loss	Uniform pore size, high permselectivity
CTA	Diffusion + Adsorption	High antithrombogenicity, improves lipids	Moiré structure, uniform flow distribution
PMMA	Adsorption (dominant)	Removes protein-bound toxins, PTH adsorption	Homogeneous structure, muscle preservation
PEPA	Convection + Adsorption	Endotoxin filtration, adjustable albumin loss	Three-layer structure, controls complement
EVAL	Diffusion	Minimal inflammation, reduces oxidative stress	Hydrophilic, uncharged, smooth surface
PAN	Adsorption + Convection	MCP-1 removal, broad uremic toxin clearance	Hydrogel structure, specific protein adsorption
Surface-modified	Variable	Reduced hypotension, heparin-free dialysis	Vitamin E, PEG, or heparin coatings

PVP = polyvinylpyrrolidone; PTH = parathyroid hormone; MCP-1 = monocyte chemoattractant protein-1

🧠 Clinical Selection Guidance by Patient Need:

High middle molecule clearance (amyloidosis, long vintage): PES or super high-flux PSf
Protein-bound toxin accumulation / cardiovascular risk: PMMA (highest adsorption)
Bleeding risk / need for heparin-free dialysis: Heparin-coated or CTA (high antithrombogenicity)
Intradialytic hypotension: Vitamin E-coated membranes
Endotoxin-sensitive / high inflammatory state: PEPA (endotoxin-blocking outer layer)
Peripheral vascular disease / oxidative stress: EVAL (reduces ROS and inflammation)
General use / best balance of safety and efficacy: PSf or PES (97% of market share)

Key takeaway: All modern membranes are biocompatible, but specific attributes (adsorption capacity, cut-off sharpness, surface charge, and coatings) allow personalized selection based on patient comorbidities and treatment goals.